Development of chemokine CXCL12-dependent immunotoxin against small cell lung cancer using in silico approaches
Small cell lung cancer (SCLC) is characterized by accelerated growth and early metastasis, making it a vigorous and deadly cancer. The majority of the patients relapse quickly and show a bad prognosis even after responding to earlier chemotherapy. Because of their high selectivity and effectiveness,...
Main Author: | Enayetul Islam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Informatics in Medicine Unlocked |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352914821001611 |
Similar Items
-
Immunotoxin Therapy for Lung Cancer
by: Li-Yi Xie, et al.
Published: (2017-01-01) -
Mechanisms of Resistance to Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A in Cancer Therapy
by: Michael Dieffenbach, et al.
Published: (2020-06-01) -
Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
by: Nathan Simon, et al.
Published: (2016-05-01) -
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
by: Brendan L. Hagerty, et al.
Published: (2020-06-01) -
Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
by: Christoph Mamot, et al.
Published: (2012-11-01)